Close
Novotech

Russia’s Sputnik V likely to be available for supply from January

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

FDA Advisory Panel to Assess Oversight of Peptide Substances

The U.S. Food and Drug Administration is preparing to...

Smart Packaging: The Strategic Imperative for Pharma’s Future (Beyond Compliance)

Smart packaging reflects key trends in the pharmaceutical industry...

PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE

A new integrated approach to long-read sequencing of archived...
- Advertisement -

Russia’s Sputnik-V COVID-19 vaccine might become available for supply as early as next month, the country’s sovereign wealth fund RDIF’s top official told ThePrint.

According to Kirill Dmitriev, the Chief Operating Officer (COO) of RDIF, they are hoping for approval in January 2021, and are “ready to supply the vaccine to a wider population within the same timeframe”.

“As we understand, the country’s government is working on a special Covid-19 inoculation programme that would be using the processes, technology and network of the Universal Immunisation Programme (UIP) currently in place,” Dmitriev said while talking about the distribution process of the vaccine once it receives approval.

“Strengthening the cold chain systems and deploying trained personnel to ensure vaccine safety would be key to the inoculation process’s ultimate success. Another important thing would be to prioritise socio-demographic groups that would be among the first to gain access to the vaccine apart from healthcare professionals,” he added.

 

Latest stories

Related stories

FDA Advisory Panel to Assess Oversight of Peptide Substances

The U.S. Food and Drug Administration is preparing to...

Smart Packaging: The Strategic Imperative for Pharma’s Future (Beyond Compliance)

Smart packaging reflects key trends in the pharmaceutical industry...

PacBio, Covaris Advance HiFi Sequencing Workflow for FFPE

A new integrated approach to long-read sequencing of archived...

Innovating Neuropathy Treatment: The Pharmaceutical Pursuit of Enhanced Oxygen Delivery

Strategies that address tissue hypoxia and metabolic dysfunction at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »